Baudax Bio Inc (BXRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BXRX Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Baudax Bio Inc.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent0.36
Cash & Short-term Investments0.00
Accounts receivable0.00
Inventories0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.98
Total Current Assets1.34
Equipment/Property/Plant Net3.67
Goodwill net8.80
Intangible Assets3.90
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset2.88
Total Assets20.58
Liabilities
Accounts Payable, Current AC7.82
Accrued Liabilities And Other Liabilities3.65
Short-term Debt4.23
Other Liabilities, Current3.27
Business Combination, Contingent Consideration, Liability, Current BU0.08
Total Current Liabilities19.05
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent2.73
Operating Lease Liability Current0.34
Operating Lease Liability Noncurrent2.53
Total Liabilities21.78
Stockholders' Equity
Common Stock Value0.12
Additional Paid In Capital Common Stock178.94
Retained Earnings / Accumulated Deficit-189.30
Other Equity-9.04
Common Stockholder's Equity-19.28
Non-controlling interests & other9.04
Total Stockholder's Equity-10.24
Liabilities & Stockholder's Equity20.58
4 historic quarters locked

Sign in to unlock the full Baudax Bio Inc balance sheet history.

About Baudax Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-065200

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.